Research programme: TDP-43 protein targeted therapuetics - WaveBreak
Latest Information Update: 12 Jan 2024
At a glance
- Originator WaveBreak
- Class Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Amyotrophic lateral sclerosis; Frontotemporal dementia
Most Recent Events
- 04 Sep 2023 Early research in Amyotrophic lateral sclerosis in United Kingdom (PO), prior to September 2023 (WaveBreak pipeline, September 2023)
- 04 Sep 2023 Early research in Frontotemporal dementia in United Kingdom (PO), prior to September 2023 (WaveBreak pipeline, September 2023)